Rigel Pharmaceuticals, Inc. (RIGL) Balance Sheet
As of 2026-06-30 (10-Q), Rigel Pharmaceuticals, Inc. (RIGL) reported total assets of $521.1M, total liabilities of $95.6M and shareholders' equity of $425.4M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $60.8M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RIGLRigel Pharmaceuticals, Inc.Follow RIGL — free
—
Price chart with a free account
- Market cap
- 899.1M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 18.6 | 33.5 | 20.9 | 15.2 | 43.5 | 17.6 | 38.3 | 76.3 | 22.5 | 30.4 | 18.9 | 24.5 | 32.8 | 56.7 | 40.6 | 60.8 | |
| Short-term investments | 229.0 | 264.8 | 191.1 | 128.0 | 82.8 | 57.1 | 77.5 | 52.2 | 75.6 | 27.0 | 106.1 | 33.7 | 24.1 | 20.6 | 114.4 | 34.5 | |
| Receivables | — | — | 5.8 | 5.8 | 0.2 | 0.0 | 0.0 | 4.1 | 10.1 | 16.0 | 15.5 | 40.3 | 30.6 | 41.6 | 51.8 | 56.0 | |
| Inventory | — | — | — | — | — | — | — | 0.9 | 1.4 | 1.6 | 6.6 | 9.1 | 5.5 | 6.0 | 11.5 | 14.4 | |
| Current assets | 250.2 | 302.5 | 220.1 | 150.5 | 129.0 | 76.2 | 117.4 | 137.0 | 119.0 | 89.0 | 154.5 | 115.9 | 99.3 | 135.1 | 240.2 | 185.5 | |
| Total assets | 257.1 | 310.0 | 226.1 | 154.1 | 131.7 | 78.1 | 119.1 | 139.1 | 147.6 | 110.4 | 167.3 | 134.3 | 117.2 | 164.0 | 513.6 | 521.1 | |
| Current liabilities | 11.5 | 12.2 | 10.3 | 14.0 | 33.8 | 22.6 | 18.3 | 27.7 | 58.2 | 40.8 | 63.6 | 65.2 | 53.3 | 63.3 | 99.2 | 95.6 | |
| Long-term debt | — | — | — | — | — | — | — | — | 10.0 | 20.0 | 20.0 | 40.0 | 60.0 | 60.0 | 52.5 | — | |
| Total liabilities | — | — | — | — | — | — | — | — | — | — | 137.0 | 147.9 | 145.9 | 160.7 | 122.1 | 95.6 | |
| Shareholders' equity | 236.1 | 289.1 | 208.3 | 128.2 | 91.4 | 55.0 | 100.6 | 109.9 | 53.8 | 34.0 | 30.4 | -13.6 | -28.6 | 3.3 | 391.5 | 425.4 |
USD millions · SEC XBRL
Rigel Pharmaceuticals, Inc. — questions
- How much cash does Rigel Pharmaceuticals, Inc. have?
- $60.8M in cash and cash equivalents as of 2026-06-30.
- What are Rigel Pharmaceuticals, Inc.'s total assets?
- $521.1M as of 2026-06-30.
- What is Rigel Pharmaceuticals, Inc.'s shareholders' equity?
- $425.4M as of 2026-06-30.
Every figure on this page comes from Rigel Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.